Apyx Medical Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $52.8M | $48.1M | $52.3M | $44.5M | $48.5M |
| Gross profit | $33.0M | $29.4M | $33.8M | $29.1M | $33.6M |
| Operating income | -$6.4M | -$18.8M | -$17.3M | -$23.6M | -$14.4M |
| Operating expenses | $39.5M | $48.2M | $53.7M | $52.7M | $48.0M |
| Cost of revenue | $19.8M | $18.7M | $18.6M | $15.4M | $14.9M |
| Cash from operations | -$8.0M | -$18.0M | -$5.2M | -$20.3M | -$10.4M |
| Capital expenditure | $1.1M | $722,000 | $533,000 | $1.0M | $723,000 |
| Free cash flow | -$9.1M | -$18.8M | -$5.8M | -$21.3M | -$11.2M |
| Total assets | $66.8M | $64.8M | $79.2M | $51.8M | $68.7M |
| Total liabilities | $52.0M | $50.5M | $52.3M | $14.0M | $14.7M |
| Total debt | — | — | $37.5M | — | — |
Shares outstanding 41.9M · Free float 79.8%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.